trial

Longitudinal Multimodal Neuroimaging Studies in Patients With First Episode Psychosis

NCTId NCT01688765
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 187 (actual)
Sponsored by Mclean Hospital
Primary completion 2022-09-23
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
187 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2012-10-17
Primary completion
2022-09-23
Eligibility
ALL · 18 Years · 45 Years

Interventions & indications

Drugs
Observational

Sponsors

Mclean HospitalLead Sponsor

Investigators

1
Dost Ongur, MD, PhDPrincipal Investigator

Sites

1 total
Belmont, United States

Facts & assertions

4 sourced
Enrollment
187
Phase
NA
Primary Completion Date
2022-09-23
Status
COMPLETED
relationships
The graph out of here
drug
Observational
drug
lead_sponsor
Mclean Hospital
company
indication
Bipolar Disorder
indication
Schizophrenia
indication
Psychotic Disorders
indication
investigator
Dost Ongur, MD, PhD
person